首页> 美国卫生研究院文献>other >Merkel Cell Carcinoma Expresses Vasculogenic Mimicry: Demonstration inPatients and Experimental Manipulation in Xenografts
【2h】

Merkel Cell Carcinoma Expresses Vasculogenic Mimicry: Demonstration inPatients and Experimental Manipulation in Xenografts

机译:默克尔细胞癌表达血管生成模仿:在示范异种移植的患者和实验操作

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Merkel cell carcinoma (MCC) is a highly virulent cutaneous neoplasm that, like melanoma, is a frequent cause of patient morbidity and mortality. The cellular mechanisms responsible for the aggressive behavior of MCC remain unknown. Vasculogenic mimicry (VM) is a phenomenon associated with cancer virulence, including in melanoma, whereby anastomosing laminin networks form in association with tumor cells that express certain endothelial genes. To determine whether VM is a factor in MCC, we employed a relevant xenograft model using two independent human MCC lines. Experimentally induced tumors were remarkably similar histologically to patient MCC, and both contained laminin networks associated with vascular endothelial-cadherin (CD144) and vascular endothelial growth factor receptor 1 (VEGFR-1) as well as Nodal expression typical of VM in melanoma. Moreover, two established chemotherapeutic agents utilized for human MCC, etoposide and carboplatin, induced necrosis in xenografts upon systemic administration while enriching for laminin networks in apparently resistant viable tumor regions that persisted. These findings for the first time establish VM-like laminin networks as a biomarker in MCC, demonstrate the experimental utility of the MCC xenograft model, and suggest that VM-rich regions of MCC may be refractory to conventional chemotherapeutic agents.
机译:默克尔细胞癌(MCC)是一种剧毒的皮肤肿瘤,与黑色素瘤一样,是导致患者发病和死亡的常见原因。负责MCC攻击行为的细胞机制仍然未知。血管生成模拟(VM)是一种与癌症毒力有关的现象,包括在黑色素瘤中,借此与表达某些内皮基因的肿瘤细胞结合形成层粘连蛋白网络。为了确定VM是否是MCC的一个因素,我们采用了两个独立的人MCC系相关的异种移植模型。实验诱导的肿瘤在组织学上与患者的MCC非常相似,并且都包含与血管内皮钙粘蛋白(CD144)和血管内皮生长因子受体1(VEGFR-1)相关的层粘连蛋白网络,以及黑色素瘤中VM典型的Nodal表达。此外,两种已建立的用于人MCC的化学治疗剂,依托泊苷和卡铂,在全身性给药后诱导异种移植物中坏死,同时在持续存在的明显耐药的肿瘤区域富集层粘连蛋白网络。这些发现首次建立了VM样层粘连蛋白网络作为MCC中的生物标志物,证明了MCC异种移植模型的实验实用性,并表明MCC富含VM的区域可能对常规化疗药物具有耐药性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号